Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds
Yan Shi1, Caroline Desponts, Jeong Tae Do
1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
Abstract:
Somatic cells can be induced into pluripotent stem cells (iPSCs) with a combination of four transcription factors, Oct4/Sox2/Klf4/c-Myc or Oct4/Sox2/Nanog/LIN28. This provides an enabling platform to obtain patient-specific cells for various therapeutic and research applications. However, several problems remain for this approach to be therapeutically relevant due to drawbacks associated with efficiency and viral genome integration. Recently, it was shown that neural progenitor cells (NPCs) transduced with Oct4/Klf4 can be reprogrammed into iPSCs. However, NPCs express Sox2 endogenously, possibly facilitating reprogramming in the absence of exogenous Sox2. In this study, we identified a small-molecule combination, BIX-01294 and BayK8644, that enables reprogramming of Oct4/Klf4-transduced mouse embryonic fibroblasts, which do not endogenously express the factors essential for reprogramming. This study demonstrates that small molecules identified through a phenotypic screen can compensate for viral transduction of critical factors, such as Sox2, and improve reprogramming efficiency.
Insights
Researchers developed a small-molecule combination to improve induced pluripotent stem cell (iPSC) generation. This approach enhances reprogramming efficiency without needing all critical viral factors, advancing cell therapy research.
Area of Science:
- Stem Cell Biology
- Molecular Biology
- Biotechnology
Background:
- Induced pluripotent stem cells (iPSCs) are generated using transcription factors like Oct4, Sox2, Klf4, and c-Myc.
- Current methods face challenges with efficiency and viral integration, limiting therapeutic applications.
- Neural progenitor cells (NPCs) can be reprogrammed using Oct4/Klf4, potentially due to endogenous Sox2 expression.
Purpose of the Study:
- To identify alternative methods for efficient iPSC generation.
- To find small molecules that can compensate for essential reprogramming factors.
- To improve the therapeutic relevance of iPSC technology.
Main Methods:
- Phenotypic screening for small molecules.
- Testing a combination of BIX-01294 and BayK8644.
- Reprogramming Oct4/Klf4-transduced mouse embryonic fibroblasts.
Main Results:
- A small-molecule combination (BIX-01294 and BayK8644) was identified.
- These molecules enabled reprogramming of mouse embryonic fibroblasts lacking essential endogenous factors.
- Small molecules compensated for viral transduction of factors like Sox2, enhancing reprogramming efficiency.
Conclusions:
- Small molecules can substitute for viral transduction of critical reprogramming factors.
- This strategy improves the efficiency of induced pluripotent stem cell generation.
- The findings offer a more therapeutically viable approach to iPSC technology.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
iPS Cell Differentiation


